AVXL
Price
$8.51
Change
-$0.23 (-2.63%)
Updated
Sep 23 closing price
Capitalization
730.96M
89 days until earnings call
TRAW
Price
$1.88
Change
-$0.03 (-1.57%)
Updated
Sep 23 closing price
Capitalization
13.28M
Interact to see
Advertisement

AVXL vs TRAW

Header iconAVXL vs TRAW Comparison
Open Charts AVXL vs TRAWBanner chart's image
Anavex Life Sciences
Price$8.51
Change-$0.23 (-2.63%)
Volume$735.31K
Capitalization730.96M
Traws Pharma
Price$1.88
Change-$0.03 (-1.57%)
Volume$52.73K
Capitalization13.28M
AVXL vs TRAW Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. TRAW commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and TRAW is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (AVXL: $8.51 vs. TRAW: $1.88)
Brand notoriety: AVXL and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 67% vs. TRAW: 45%
Market capitalization -- AVXL: $730.96M vs. TRAW: $13.28M
AVXL [@Biotechnology] is valued at $730.96M. TRAW’s [@Biotechnology] market capitalization is $13.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 2 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 2 green, 3 red.
According to our system of comparison, TRAW is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while TRAW’s TA Score has 6 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 5 bearish.
  • TRAW’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а -5.02% price change this week, while TRAW (@Biotechnology) price change was -8.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($731M) has a higher market cap than TRAW($13.3M). AVXL YTD gains are higher at: -20.763 vs. TRAW (-78.829). TRAW has higher annual earnings (EBITDA): -20.26M vs. AVXL (-45.88M). AVXL has more cash in the bank: 101M vs. TRAW (13.1M). TRAW has higher revenues than AVXL: TRAW (2.9M) vs AVXL (0).
AVXLTRAWAVXL / TRAW
Capitalization731M13.3M5,496%
EBITDA-45.88M-20.26M226%
Gain YTD-20.763-78.82926%
P/E RatioN/A0.45-
Revenue02.9M-
Total Cash101M13.1M771%
Total Debt88.2KN/A-
FUNDAMENTALS RATINGS
AVXL vs TRAW: Fundamental Ratings
AVXL
TRAW
OUTLOOK RATING
1..100
5583
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5849
P/E GROWTH RATING
1..100
10025
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (22) in the Biotechnology industry is in the same range as AVXL (53). This means that TRAW’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

TRAW's Price Growth Rating (49) in the Biotechnology industry is in the same range as AVXL (58). This means that TRAW’s stock grew similarly to AVXL’s over the last 12 months.

TRAW's P/E Growth Rating (25) in the Biotechnology industry is significantly better than the same rating for AVXL (100). This means that TRAW’s stock grew significantly faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLTRAW
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AAEMX12.98-0.01
-0.08%
Alger Emerging Markets A
TEMSX9.89-0.02
-0.20%
Nuveen Emerging Markets Eq Retiremt
AWSSX18.04-0.07
-0.39%
Invesco Global Core Equity R6
MITGX34.24-0.20
-0.58%
MFS Massachusetts Investors Tr R1
WAGOX4.24-0.03
-0.70%
Wasatch Global Opportunities Investor

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-2.63%
PLRX - AVXL
47%
Loosely correlated
-2.67%
TENX - AVXL
45%
Loosely correlated
+1.56%
RXRX - AVXL
40%
Loosely correlated
-3.41%
SYRE - AVXL
37%
Loosely correlated
+4.77%
SRRK - AVXL
37%
Loosely correlated
+3.59%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-1.57%
SLGL - TRAW
45%
Loosely correlated
+2.86%
RAPT - TRAW
45%
Loosely correlated
+4.12%
WHWK - TRAW
39%
Loosely correlated
+1.05%
AVXL - TRAW
35%
Loosely correlated
-2.63%
GTBP - TRAW
29%
Poorly correlated
+3.14%
More